Official sources said the UN health agency is yet to share the label and description of the products with the Central Drugs Standard Control Organization (CDSCO) to ascertain where they were manufactured. However, on the basis of the available information, CDSCO along with regulatory authorities in Haryana has started investigation into the matter immediately, he said. Many children's kidneys have also suffered a lot due to the use of this medicine.
An official source said, “All necessary steps will be taken. WHO, as a strong regulatory authority, has been requested to share a report and label/photographs of the products, etc., with CDSCO on alleged medical products linked to death cases at the earliest.” Sources say that the WHO had informed the Drug Controller General of India on September 29 that it was providing technical assistance to The Gambia.
syrups made in india which are banned
These four syrups are produced by the Indian company Medan Pharmaceuticals Limited. It was told by the WHO that all the four 'substandard' medicines have been prepared in Haryana. Name the syrups which were banned.
Promethazine Oral Solution
Kofexmalin Baby Cough Syrup
Makoff Baby Cough Syrup
Magrip N Cold Syrup
The WHO also said that lab analysis of samples of each of the four drugs confirmed that they contained unacceptable amounts of diethylene glycol and ethylene glycol.
What are the risks associated with these syrups?
Consumption of syrup can cause many problems to humans. The WHO, citing the risks associated with these products, said that diethylene glycol and ethylene glycol can prove fatal to humans. Due to this the following problems may occur.
stomach ache
Vomiting
Diarrhea
Headache
kidney problems
difficulty passing urine
change in mental state
Possibility of serious damage to the kidney, which can even kill the patient.
The WHO said in its statement, it is extremely important to detect and eliminate these substandard products to prevent harm to patients.
No comments:
Post a Comment